Brookfield Renewable Partners LP
BEP.UN
TELUS Corp
T
BCE Inc
BCE
Enbridge Inc
ENB
TC Energy Corp
TRP
CA Stock MarketDetailed Quotes
ONC Oncolytics Biotech Inc
- 0.930
- -0.060-6.06%
15min DelayMarket Closed Mar 10 16:00 ET
74.42MMarket Cap-2.27P/E (TTM)
1.000High0.920Low140.03KVolume1.000Open0.990Pre Close131.70KTurnover2.08052wk High0.19%Turnover Ratio80.02MShares0.87052wk Low-0.41EPS TTM70.30MFloat Cap204.250Historical HighLossP/E (Static)75.59MShs Float0.480Historical Low-0.41EPS LYR8.08%Amplitude--Dividend TTM12.40P/B1Lot Size--Div YieldTTM
Oncolytics Biotech Inc Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 5.21%-26.97M | -28.12%-7.85M | 19.87%-4.83M | -21.81%-28.45M | -3.12%-6.12M | -41.98%-6.03M | -22.38%-8.47M | -25.22%-7.83M | -4.11%-23.36M | 6.25%-5.94M |
| Net income from continuing operations | -14.26%-31.71M | -103.01%-8.02M | 3.85%-9.54M | -11.75%-27.75M | 53.83%-3.95M | -125.16%-9.93M | -46.05%-7.44M | 5.04%-6.44M | 5.58%-24.84M | -10.36%-8.55M |
| Operating gains losses | 58.42%-2.08M | 95.57%-203K | 72.14%-197K | -211.71%-5M | -6,943.28%-4.59M | 44.33%-707K | 153.87%444K | -136.64%-155K | -492.42%-1.61M | -77.42%67K |
| Depreciation and amortization | 5.21%424K | -8.41%98K | 1.94%105K | 2.81%403K | 8.08%107K | 6.19%103K | -1.65%96K | -1.02%97K | -13.27%392K | 2.16%99K |
| Remuneration paid in stock | 31.67%2.72M | 57.58%1.2M | -40.67%445K | -13.04%2.07M | 1.34%759K | 50.00%750K | -50.62%242K | -50.39%317K | -37.85%2.38M | -33.64%749K |
| Other non cashItems | 95.77%139K | 122.22%40K | -43.24%42K | 193.42%71K | 112.86%18K | 289.47%74K | 251.67%75K | -500.00%-96K | -182.61%-76K | -635.33%-140K |
| Change In working capital | 100.45%3.54M | -162.91%-960K | 17.44%4.32M | 351.41%1.77M | -17.07%1.53M | 350.92%3.68M | -17.03%-1.88M | -136.68%-1.56M | 143.06%391K | 1,492.02%1.84M |
| -Change in receivables | -110.47%-53K | ---- | ---- | 46.67%506K | ---- | ---- | ---- | -127.36%-209K | 144.46%345K | 96.09%-24K |
| -Change in prepaid assets | 75.16%1.36M | ---- | ---- | 162.31%777K | ---- | ---- | ---- | 94.47%-65K | -257.31%-1.25M | 176.77%1.32M |
| -Change in payables and accrued expense | 1,664.10%1.22M | ---- | ---- | -104.69%-78K | ---- | ---- | ---- | -2,424.59%-1.42M | 808.20%1.66M | 195.02%329K |
| -Change in other current liabilities | 287.35%1.29M | ---- | ---- | 194.32%332K | ---- | ---- | ---- | --0 | -254.39%-352K | --0 |
| -Change in other working capital | -221.05%-276K | ---- | ---- | 1,441.18%228K | ---- | ---- | ---- | 204.44%137K | 91.24%-17K | 10,881.81%211K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 5.21%-26.97M | -28.12%-7.85M | 19.87%-4.83M | -21.81%-28.45M | -3.12%-6.12M | -41.98%-6.03M | -22.38%-8.47M | -25.22%-7.83M | -4.11%-23.36M | 6.25%-5.94M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -101.18%-239K | -100.00%-6K | -100.47%-32K | 199.11%20.22M | 99.99%-3K | 75,277.78%6.77M | 58,408.29%6.79M | 18,625.00%6.67M | -7,033.92%-20.4M | -27,114.97%-20.35M |
| Net PPE purchase and sale | -2,887.50%-239K | -100.00%-6K | ---32K | 85.45%-8K | -400.00%-3K | --0 | --0 | 86.11%-5K | 80.77%-55K | 101.34%1K |
| Net investment purchase and sale | --0 | --0 | --0 | 199.42%20.23M | --0 | --6.77M | --6.79M | --6.67M | ---20.35M | ---20.35M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -101.18%-239K | -100.00%-6K | -100.47%-32K | 199.11%20.22M | 99.99%-3K | 75,277.78%6.77M | 58,408.29%6.79M | 18,625.00%6.67M | -7,033.92%-20.4M | -27,114.97%-20.35M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -79.26%6.64M | 91.68%3.34M | -100.81%-173K | 162.14%31.99M | -70.32%1.74M | 1,727.38%21.29M | 2,262.59%3.69M | 5.13%5.27M | -63.03%12.21M | 11,305.07%5.87M |
| Net issuance payments of debt | 14.50%-348K | 3.85%-100K | 21.57%-80K | -6.82%-407K | -1.96%-104K | -6.25%-102K | -6.76%-100K | -13.48%-101K | -4.10%-381K | -26.71%-102K |
| Net common stock issuance | -78.12%6.92M | 133.79%3.44M | -100.74%-158K | 151.47%31.62M | -75.37%1.47M | 1,591.36%21.33M | 1,279.95%3.45M | 5.52%5.37M | -61.80%12.57M | 66,507.21%5.97M |
| Proceeds from stock option exercised by employees | -91.68%65K | --0 | 3.17%65K | 6,408.33%781K | --375K | --63K | ---- | ---- | -97.44%12K | --0 |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -79.26%6.64M | 91.68%3.34M | -100.81%-173K | 162.14%31.99M | -70.32%1.74M | 1,727.38%21.29M | 2,262.59%3.69M | 5.13%5.27M | -63.03%12.21M | 11,305.07%5.87M |
| Net cash flow | ||||||||||
| Beginning cash position | 199.26%34.91M | -50.98%19.6M | 41.84%24.85M | -71.73%11.67M | 23.54%39.98M | -47.99%17.52M | -59.80%15.87M | -71.73%11.67M | 32.17%41.26M | -32.70%32.36M |
| Current changes in cash | -186.54%-20.57M | -2.92%-4.51M | -122.87%-5.04M | 175.33%23.77M | 78.52%-4.39M | 812.55%22.03M | 129.78%2.02M | 422.68%4.11M | -406.46%-31.55M | -215.95%-20.42M |
| Effect of exchange rate changes | 406.32%1.6M | 225.29%857K | -149.31%-215K | -126.67%-522K | -144.29%-684K | -75.28%436K | -137.70%-369K | 118.81%95K | 870.47%1.96M | 23.07%-280K |
| End cash Position | -54.34%15.94M | -54.34%15.94M | -50.98%19.6M | 199.26%34.91M | 199.26%34.91M | 23.54%39.98M | -48.00%17.52M | -59.80%15.87M | -71.73%11.67M | -71.73%11.67M |
| Free cash from | 4.40%-27.21M | -28.15%-7.85M | 19.34%-4.86M | -21.55%-28.46M | -3.18%-6.13M | -41.68%-6.03M | -22.17%-8.47M | -24.59%-7.83M | -3.04%-23.41M | 7.36%-5.94M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion with Explanatory Notes | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Trending Stocks
Dividend Kings of Canada Dividend Kings of Canada
Dividend Kings In Canada are companies that have increased their Dividend per share for the most consecutive years, reflecting a strong business model and robust financials, and are likely to outperform the market with less volatility. Dividend Kings In Canada are companies that have increased their Dividend per share for the most consecutive years, reflecting a strong business model and robust financials, and are likely to outperform the market with less volatility.